Legacy Wealth Asset Management’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-813	Closed	-$266K	–	365
2024 Q4	$266K	Sell	813 -23	-3%	-$7.24K	0.07%	320
2024 Q3	$251K	Buy	836 +13	+2%	+$3.98K	0.07%	325
2024 Q2	$271K	Buy	823 +22	+3%	+$7.78K	0.08%	306
2024 Q1	$317K	Buy	801 +2	+0.3%	+$740	0.09%	292
2023 Q4	$281K	Buy	799 +2	+0.3%	+$708	0.09%	299
2023 Q3	$299K	Sell	797 -18	-2%	-$6.96K	0.11%	279
2023 Q2	$312K	Buy	815 +10	+1%	+$3.57K	0.11%	284
2023 Q1	$279K	Buy	+805	New	+$235K	0.1%	296
2022 Q4	–	Sell	-877	Closed	-$216K	–	348
2022 Q3	$216K	Buy	877 +9	+1%	+$2.74K	0.09%	299
2022 Q2	$262K	Sell	868 -1	-0.1%	-$325	0.11%	250
2022 Q1	$357K	Buy	869 +6	+0.7%	+$2.35K	0.13%	229
2021 Q4	$405K	Sell	863 -24	-3%	-$10.3K	0.14%	225
2021 Q3	$377K	Sell	887 -25	-3%	-$10.5K	0.17%	214
2021 Q2	$327K	Sell	912 -42	-4%	-$13.9K	0.15%	237
2021 Q1	$269K	Sell	954 -6	-0.6%	-$1.72K	0.12%	253
2020 Q4	$272K	Buy	+960	New	+$269K	0.14%	244